Meloxicam
|
- ₹4600 - ₹20250
- Product name: Meloxicam
- CAS: 71125-38-7
- MF: C14H13N3O4S2
- MW: 351.4
- EINECS:615-253-8
- MDL Number:MFCD00868752
- Synonyms:MeloxicaM, BP;MeloxicaM API;4-Hydroxy-2-Methyl-N-(5-Methylthiazol-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxaMide 1,1-dioxide;Meloxicam Solution, 100ppm;4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxid;Coxicam;MOBEC
4 prices
Selected condition：
Brand
- TCI Chemicals (India)
- Sigma-Aldrich(India)
Package
- 100MG
- 500MG
- 5G
- 25G
- ManufacturerTCI Chemicals (India)
- Product numberM1959
- Product descriptionMeloxicam
- Packaging5G
- Price₹4600
- Updated2022-05-26
- Buy
- ManufacturerTCI Chemicals (India)
- Product numberM1959
- Product descriptionMeloxicam
- Packaging25G
- Price₹13300
- Updated2022-05-26
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberPHR1799
- Product descriptionMeloxicam Pharmaceutical Secondary Standard; Certified Reference Material
- Packaging500MG
- Price₹16215.85
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product number444800
- Product descriptionMeloxicam - CAS 71125-38-7 - Calbiochem A cell-permeable, non-steroidal anti-inflammatory drug (NSAID) of the oxicam family which preferentially inhibits the inducible isoform of COX-2 (IC??
- Packaging100MG
- Price₹20250
- Updated2022-06-14
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| TCI Chemicals (India) | M1959 | Meloxicam | 5G | ₹4600 | 2022-05-26 | Buy |
| TCI Chemicals (India) | M1959 | Meloxicam | 25G | ₹13300 | 2022-05-26 | Buy |
| Sigma-Aldrich(India) | PHR1799 | Meloxicam Pharmaceutical Secondary Standard; Certified Reference Material | 500MG | ₹16215.85 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | 444800 | Meloxicam - CAS 71125-38-7 - Calbiochem A cell-permeable, non-steroidal anti-inflammatory drug (NSAID) of the oxicam family which preferentially inhibits the inducible isoform of COX-2 (IC?? | 100MG | ₹20250 | 2022-06-14 | Buy |
Properties
Melting point :255 °C
Density :1.613±0.06 g/cm3(Predicted)
storage temp. :2-8°C
solubility :DMSO: soluble
form :Off-white solid
pka :4.08 in water; 4.24 ± 0.01 in water/ethanol (1:1); 4.63 ± 0.03 in water/ethanol (1:4)
color :yellow
Water Solubility :practically insoluble in water(0.154 mg/mL), with higher solubility observed in strong acids and bases.
Merck :14,5826
BCS Class :2(CLogP), 4 (LogP)
Stability :Stable. Incompatible with strong oxidizing agents.
InChI :InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)
InChIKey :ZRVUJXDFFKFLMG-UHFFFAOYSA-N
SMILES :S1(=O)(=O)C2=CC=CC=C2C(O)=C(C(NC2=NC=C(C)S2)=O)N1C
EPA Substance Registry System :2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide (71125-38-7)
Density :1.613±0.06 g/cm3(Predicted)
storage temp. :2-8°C
solubility :DMSO: soluble
form :Off-white solid
pka :4.08 in water; 4.24 ± 0.01 in water/ethanol (1:1); 4.63 ± 0.03 in water/ethanol (1:4)
color :yellow
Water Solubility :practically insoluble in water(0.154 mg/mL), with higher solubility observed in strong acids and bases.
Merck :14,5826
BCS Class :2(CLogP), 4 (LogP)
Stability :Stable. Incompatible with strong oxidizing agents.
InChI :InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)
InChIKey :ZRVUJXDFFKFLMG-UHFFFAOYSA-N
SMILES :S1(=O)(=O)C2=CC=CC=C2C(O)=C(C(NC2=NC=C(C)S2)=O)N1C
EPA Substance Registry System :2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide (71125-38-7)
Safety Information
| Symbol(GHS): |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | ||||||||||||||
| Hazard statements: |
|
||||||||||||||
| Precautionary statements: |
|
Description
Known as a nonsteroidal anti-inflammatory drug (NSAID), Meloxicam is commonly used to treat pain or inflammation caused by rheumatoid arthritis and osteoarthritis in adults. It is also used to treat juvenile rheumatoid arthritis in children who are at least 2 years old. It is effective to reduce pain, inflammation, swelling, and stiffness of the joints. Developed by Boehringer-Ingelheim, Meloxicam is a derivative of oxicam that can relieve the symptoms of arthritis, primary dysmenorrhea, fever with analgesic and antipyretic properties. Meloxicam was approved for use in April 2000.Anti-inflammatory effects of meloxicam function by inhibiting the prostaglandin synthetase (cyclooxygenase 1 and 2) which results in a decrease of the synthesis of prostaglandins. As prostaglandins are chemicals that contribute to inflammation especially within joints, which leads to the common symptoms of pain, tenderness, and swelling associated with arthritis, inhibition of their synthesis can be associated with the analgesic and antipyretic effects of meloxicam. As a result, inflammation and its accompanying symptoms are reduced. Meloxicam starts to relieve pain about 30 to 60 minutes after administration.
Related product price
- 2,2'-Dithiobis(benzothiazole)
₹2600-6852.23 - Fosthiazate
₹60132.88 - Benzothiazole
₹1628-332868.75